About Us
Fund
Support
Return
About Us
Fund
Support
Return
Our DNA
News
Join Our Team
Contact
Investor Portal
Our Eco-design Approach
NEWS
View All
2022
2021
2020
2019
2018
2017
2016
2015
2014
ARCHIMED’s MED II fund earns a 6x return on EUROLyser, its first exit
May
9,
2022
ARCHIMED sells health ingredients developer Fytexia to Associated British Foods
February
2,
2022
ARCHIMED buys CARSO, a leader in purity testing for pharma and other industries
December
16,
2021
ARCHIMED reaches agreement to sell Bomi Group to UPS
December
16,
2021
ARCHIMED buys a majority stake in SUANFARMA a leading manufacturer and distributor of active pharmaceutical and nutraceutical ingredients
November
18,
2021
ARCHIMED buys Cardioline, Europe’s leader in cardiology-focused telemedicine
November
17,
2021
<
1
2
3
4
…
12
>